mivazerol has been researched along with Tachyarrhythmia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanin, I; Kim, SY; Raikoff, K; Wülfert, E | 1 |
| Demenge, P; Durand, A; Godin-Ribuot, D; Mazenot, C; Ribuot, C | 1 |
2 other study(ies) available for mivazerol and Tachyarrhythmia
| Article | Year |
|---|---|
Mivazerol, a selective alpha 2-adrenoceptor agonist, attenuates tachycardia by intrathecal injection of N-methyl-D-aspartate in the rat.
Topics: Adrenergic alpha-Agonists; Animals; Heart Rate; Imidazoles; Injections, Spinal; Male; N-Methylaspartate; Rats; Rats, Sprague-Dawley; Tachycardia | 1996 |
Histamine H3-receptor stimulation is unable to modulate noradrenaline release by the isolated rat heart during ischaemia-reperfusion.
Topics: Action Potentials; Adrenergic alpha-Agonists; Animals; Hemodynamics; Histamine Agonists; Imidazoles; In Vitro Techniques; Methylhistamines; Myocardial Ischemia; Myocardial Reperfusion Injury; Norepinephrine; Rats; Rats, Wistar; Receptors, Histamine H3; Tachycardia; Ventricular Fibrillation | 1999 |